SDIC Fund Management is a private equity that manages funds and raises nearly 60 billion yuan at present. The management funds cover financial institutions, social security funds, state-owned and private capital, and it is one of the largest professional private equity management institutions in China.
Hipot is a technological innovation company dedicated to providing hydrogen fuel cell commercial vehicle transportation solutions.
Tianmei Times
Seed Round in 2025
Tianmei Times is a subsidiary of Techcomp ( Tianmei Group). Tianmei Times focusing on the fields of spectroscopy, chromatograph and mass spectrometry, life science laboratory equipment, etc.
NASN Automotive Electronics Co., Ltd. is a manufacturer based in Shanghai, China, specializing in electronic chassis control products and autonomous driving technologies for the automotive market. The company offers a range of products, including the NBooster intelligent brake system, brushless electric steering EPS controller, and wire control systems. By focusing on research and development, production, and sales, NASN aims to provide advanced and comprehensive solutions that enhance vehicle safety and intelligence, catering to the growing demand for innovative automotive technologies in China.
Estun Codroid is a company that develops and applies generic intelligent robot technology. Estun Codroid focuses on promoting embodied intelligence technology and offers a variety of general intelligent human-machine collaboration robot products and application solutions to satisfy the needs of a broad market, including industry and services.
Beijing Shenzhou Puhui Technology is a high-tech company that specializes in AI big data, simulation training, and marine technology. Since its founding, it has focused on technology creation, technical consulting services, and the sale of associated products, all while advancing technological research and development and aiming for client success. Adhere to the combination of indigenous innovation and imported innovation, deliver world-class goods and expert services to the manufacturing, scientific research, and education sectors, aid users in enhancing their research and development capabilities and efficiency, and advance regional technological advancement.
Calterah specializes in the development of CMOS single-chip millimeter-wave radar sensors aimed at automotive applications. The company produces system-on-chip (SoC) products that integrate radar signal processing baseband technology, facilitating the design and implementation of mmWave radar sensors. These sensors find applications in various sectors, including both industrial and consumer markets, supporting technologies related to environmental sensing, autonomous obstacle avoidance, and radar imaging. Calterah's innovations contribute significantly to advancements in autonomous driving and related technologies.
Newcosemi Technology is a domestically owned integrated circuit design company specializing in the development and production of mid-to-high-end communication chips and high-definition display circuits. Utilizing its proprietary technology, the company focuses on electronic display applications, particularly for smartphones and televisions. This enables electronics manufacturers to incorporate advanced integrated circuit technology into their products, enhancing performance and display quality.
MITRO Biotech is a domestic molecular imaging and medical research and development outsourcing company that specializes in providing comprehensive solutions for drug development. The firm aims to shorten the drug development cycle and minimize the risk of failure for pharmaceutical companies and research institutes, both domestically and internationally. Its services encompass drug screening, biodistribution studies, pharmacokinetic research, and pharmacodynamic evaluation. By offering these technical research services, MITRO Biotech enables pharmaceutical developers to expedite the introduction of new drugs to trials and markets.
Zhejiang Xinglaihe is a modern agricultural machinery manufacturing company. It is committed to the research and development, manufacturing, and sale of high-speed rice transplanters, tractors, diesel engines, and other agricultural machinery.
Tongxing Intelligence is a manufacturer of domestic self-contained automotive bus tool chains. They offer reliable products, complete services, and reasonable prices. It has provided independent, innovative solutions to engineering problems in automotive research and development, manufacturing, and industrial production for over two decades.
Shunke Zhilian is a manufacturer of accessories for electric vehicles. It is a national high-tech enterprise integrating R&D, design, manufacturing, sales and after-sales service.
Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.
Adlai Nortye Biopharma Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the research and development of innovative cancer therapies and treatments for metabolic diseases. Founded in 2004 and based in Hangzhou, China, the company has established research and development and clinical operations in both China and the United States. Adlai Nortye has a diverse pipeline of over ten drug candidates, including several in various stages of clinical development, such as buparlisib (AN2025), palupiprant (AN0025), and AN4005, alongside preclinical candidates like AN8025, AN9025, and AN1025. The company emphasizes collaborations and internal discoveries to advance its strategic focus on oncology.
CanSemi is a semiconductor manufacturing company based in China, specializing in the production of microprocessors, power management chips, analog chips, and power discrete devices. The company operates as an integrated device manufacturer (IDM), focusing on addressing the domestic demand for chips in various sectors, including the Internet of Things, automotive electronics, industrial control, and 5G technology. By providing these essential components, CanSemi plays a significant role in supporting the growing technological landscape in China.
EpimAb Biotherapeutics is a privately owned biopharmaceutical company dedicated to generating novel bi-specific antibody therapeutics based on its proprietary FIT-Ig (Fabs-In-Tandem) platform. Monoclonal antibodies have transformed the treatment of human diseases, including inflammatory and autoimmune diseases, cancer, severe infections and many rare conditions over the course of the past two decades. Bi-specific antibodies are engineered from two different monoclonal antibodies and combine their key features into one molecule. As a novel drug class, bi-specifics provide additional options for the treatment of many life-threatening diseases such as cancer. However, even minor modifications to any pharmaceutically active biologic such as an antibody can significantly change the properties critical to its development, such as its binding properties, the pharmacokinetics, its stability, solubility and the ability to produce it in sufficient quantities at reasonable costs. This challenge has prevented a majority of bi-specific antibodies of potential interest to scientists and clinicians from advancing into clinical development because their drug-like features were compromised. Thus, the need for a new generation of bi-specific antibody therapeutics in the pharmaceutical industry remains high.
Zhejiang Leapmotor Technology Co., Ltd. is a prominent electric vehicle manufacturer based in Hangzhou, China. Established in 2015, the company focuses on the design, research and development, and production of intelligent electric vehicles. Leapmotor is committed to advancing technologies related to intelligent driving, motor electronic control, battery systems, and cloud computing for vehicle networking solutions. The company benefits from significant investment by Zhejiang Dahua Technology Co., Ltd., which provides robust financial support and expertise in technology research, development, and quality management. Leapmotor prioritizes technological innovation and industrial design, aiming to enhance process quality in its operations.
Zylox Medical Device Co. was established in 2012 in Hangzhou by a team of experienced professionals who returned to China after working in prominent medical device companies in the US and Europe. The company specializes in developing innovative interventional and implantable devices for peripheral and neurovascular applications. Its product portfolio includes a range of devices such as PTA balloons, drug-coated PTA balloons, stents, and thrombectomy devices. Zylox is committed to providing high-quality medical solutions aimed at improving patient care and enhancing the capabilities of healthcare professionals. The company continues to expand its product offerings to address various vascular conditions both in China and internationally.
Jianan Nongmu builds a new model of the agriculture and animal husbandry industry. The company is divided into three business units: digital supply chain financing, smart breeding, and smart logistics. Jianan Nongmu is dedicated to bringing back the agriculture and animal husbandry sectors of the economy through science and technology.
Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia.
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.
“Peijia Medical” was established in early 2012, by returned oversea Chinese expert in professional medical device industry, providing R&D and production of interventional medical products. The company with register capital of RMB￥30 million is located in Suzhou Industrial Park, Suzhou city of Jiangsu Province. The city of Suzhou is famously named as "earthly paradise in China" and the Industrial Park beside Jinji Lake is called as “new paradise of venture capital investment”. The company covers an area of about 10000 sqm, within which laboratory and controlled environment room taking about 1800 sqm. The company has state of the art interior design with western high tech modern style infused with Suzhou oriental garden style. The office building, laboratory, and controlled environment production rooms are fully put into operation now.
EpimAb Biotherapeutics is a privately owned biopharmaceutical company dedicated to generating novel bi-specific antibody therapeutics based on its proprietary FIT-Ig (Fabs-In-Tandem) platform. Monoclonal antibodies have transformed the treatment of human diseases, including inflammatory and autoimmune diseases, cancer, severe infections and many rare conditions over the course of the past two decades. Bi-specific antibodies are engineered from two different monoclonal antibodies and combine their key features into one molecule. As a novel drug class, bi-specifics provide additional options for the treatment of many life-threatening diseases such as cancer. However, even minor modifications to any pharmaceutically active biologic such as an antibody can significantly change the properties critical to its development, such as its binding properties, the pharmacokinetics, its stability, solubility and the ability to produce it in sufficient quantities at reasonable costs. This challenge has prevented a majority of bi-specific antibodies of potential interest to scientists and clinicians from advancing into clinical development because their drug-like features were compromised. Thus, the need for a new generation of bi-specific antibody therapeutics in the pharmaceutical industry remains high.
Qingtuanshe, founded in 2013, is a university part-time employment and flexible platform that is committed to more users. Qingtuanshe offers safer, richer, and more efficient part-time services to professional part-time recruitment services for more companies. As of January 2019, the registered users of Qingtuanshe is 6 million+, the number of registered companies is 100,000+, and the number of part-time applicants per day reached 240,000.
Zylox Medical Device Co. was established in 2012 in Hangzhou by a team of experienced professionals who returned to China after working in prominent medical device companies in the US and Europe. The company specializes in developing innovative interventional and implantable devices for peripheral and neurovascular applications. Its product portfolio includes a range of devices such as PTA balloons, drug-coated PTA balloons, stents, and thrombectomy devices. Zylox is committed to providing high-quality medical solutions aimed at improving patient care and enhancing the capabilities of healthcare professionals. The company continues to expand its product offerings to address various vascular conditions both in China and internationally.
Banma Network Technologies is a global platform focused on providing innovative solutions for the automotive and transportation sectors. The company specializes in developing smart car operating systems and digital transportation services, aiming to enhance the connectivity between vehicles and cloud technology. By opening its AliOS in-car operating system to developers and car manufacturers, Banma seeks to facilitate the integration of connected car features, ultimately improving the overall user experience in smart mobility. Through its efforts, Banma Network is positioned to play a significant role in transforming the future of transportation.
Xinjinghe Laser Technology Development (Beijing) Co., Ltd. is a company that focuses on high-end manufacturing industries such as aerospace, navigation, and nuclear power. It specializes in complicated metal component customisation, product design and optimization, and software customization. Development and sales, technical advice and services, product remanufacturing and repair, 3D printing equipment manufacturing and sales of national high-tech businesses, is China's leading provider of metal additive/subtractive manufacturing technology comprehensive solutions.
RootCloud is a Beijing-based cloud computing platform founded in 2016 that specializes in Internet of Things (IoT) and industrial applications. The company connects industrial assets through various layers, including connection, platform, and application layers, to empower industries end-to-end. RootCloud targets machine manufacturers, equipment users, governmental regulatory agencies, and social organizations, offering services that encompass online machine management, smart manufacturing, research and development, and energy solutions. With over 10 years of experience, the company provides IoT and big data services globally, focusing on life-cycle management and digital transformation for large-scale manufacturing enterprises. By delivering software-as-a-service on the public cloud, RootCloud develops digital applications and solutions that enhance operational efficiency and improve product quality for its clients.
LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.
Xinjinghe Laser Technology Development (Beijing) Co., Ltd. is a company that focuses on high-end manufacturing industries such as aerospace, navigation, and nuclear power. It specializes in complicated metal component customisation, product design and optimization, and software customization. Development and sales, technical advice and services, product remanufacturing and repair, 3D printing equipment manufacturing and sales of national high-tech businesses, is China's leading provider of metal additive/subtractive manufacturing technology comprehensive solutions.
Zensun (Shanghai) Sci & Tech Co., Ltd. is a biopharmaceutical company focusing on the development of innovative ‘first in class’ bio-therapeutic products for the treatment of serious and life-threatening unmet medical needs. They discover new medicines using novel disease specific targets and innovative technologies. The patented discoveries are then developed into therapies. With adherence to the tenet of “healing for life”, we hope to transform the lives of heart failure and cancer patients by providing them with drugs that treat their disease and not the symptoms. Zensun’s current pipeline covers cardiovascular disease treatment, anti-cancer drugs, and treatments for energy metabolism disorders.
Ninebot Inc. is a company that specializes in the design, development, manufacturing, distribution, and sale of short-distance personal transportation products. Founded in 2012 by Gao Lufeng, the company is headquartered in Beijing, China. Ninebot's product offerings include eco-friendly, electric, and self-balancing vehicles aimed at facilitating short-range commuting. The company serves a diverse customer base through a network of distributors and retail outlets both in China and internationally.
United Imaging Healthcare develops and manufactures medical equipment and solutions. Its solutions cover areas of diagnostics, radiotherapy, and healthcare information technology solutions. United Imaging Healthcare offers medical imaging products such as computed tomography, molecular imaging, magnetic resonance, and X-ray radiography products, radiotherapy equipment, and uCloud UIH Intelligent Medical Cloud, a medical cloud platform for medical resource sharing and mass diagnostic data mining. It also provides customer, technical support, dispatching, and training services. United Imaging Healthcare began operation in 2011, with its headquarters in Shanghai in China. It has locations in Concord, Cleveland, Houston, Wuhan, and Shenzhen.
CF PharmTech, Inc. is a specialty pharmaceutical company based in Suzhou, China, focused on the development and manufacturing of inhalation products for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. Founded in 2007, the company offers a range of products including metered dose inhalers, dry powder inhalers, nasal sprays, and nebulizers. In addition to its product offerings, CF PharmTech provides contract manufacturing organization (CMO) services and is actively involved in research and development in its specialized field. The company aims to provide high-quality and affordable medicines to enhance patient care and management of respiratory conditions, catering to a global market. Its headquarters are strategically located in the Caohu District, ensuring convenient transportation access to major cities like Shanghai and Beijing.
Novus Pharmaceuticals is a technology platform. The company provides solid oral preparations and human nutrition and health care products. The company's products dosage forms include sterile powder injection, sterile water injection, hard capsule, and tablet. They help people.
Tianjin CanSino Biotech Inc. is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices.
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.
Novogene Co., Ltd. is a prominent global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics. Founded in 2011 and headquartered in Beijing, China, the company offers a wide range of genomic solutions, including human genome sequencing, cancer genomic profiling, and single-cell sequencing, as well as clinical-grade whole exome sequencing services. Novogene also developed innovative products like NovoFocus, a companion diagnostic assay for PARP inhibitor therapies, and NovoNeoantigen, a bioinformatics pipeline for identifying cancer neoantigens. With the largest sequencing capacity in the world and a workforce of approximately 1,800 employees, Novogene has established itself as a leader in the genomics field, holding 49 NGS-related patents and contributing to over 1,850 published customer research papers in prestigious scientific journals. The company’s founder, Dr. Ruiqiang Li, is recognized as an expert in genomics and bioinformatics, having significantly advanced the field through his research and innovative software development.
Innovent Biologics, Inc. is a leading biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacture, and commercialization of monoclonal antibodies. The company focuses on various therapeutic areas, including oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody used in the treatment of several cancers, including Hodgkin’s lymphoma and esophageal carcinoma. Innovent is also developing a range of additional drug candidates, such as biosimilars for rituximab and adalimumab, as well as novel monoclonal antibodies targeting conditions like hypercholesterolemia and different types of cancer. With a robust pipeline and over 30 strategic collaborations with global pharmaceutical companies, Innovent is well-positioned in the biopharmaceutical landscape. The company's founders and management team bring extensive experience in biologics, having participated in the launch of notable products across international markets. Innovent was founded in 2011 and has established itself as a prominent player in the biotechnology sector in China.
GBase is a Chinese company that specializes in developing database software solutions. It serves a diverse range of industries, including finance, telecommunications, government, energy, transportation, and national defense. By providing domestic-developed software, GBase enables enterprises to leverage robust database technologies tailored to their specific needs. The company's focus on serving critical sectors underscores its commitment to enhancing data management and operational efficiency for its clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.